Purpose The purpose of this study was to perform a systematic review and meta-analysis of prospective cohort studies that examined the relationship between anxiety disorders, or clinically significant anxiety symptoms, at baseline and all-cause mortality at followup relative to control participants without clinically significant anxiety. Methods PubMed, EMBASE, PsycInfo, and CINAHL were searched through July 2015, along with manual searches of published reviews and forward and backward snowball searches of included studies. Studies were excluded if anxiety was not defined with a standardized instrument, or if participants were followed-up for 1 year or less. The initial search yielded 7901 articles after the removal of duplicates, of which 328 underwent full-text screening. Results Forty-two estimates from 36 articles were included in the meta-analysis with a total sample of 127,552 participants and over 11,573 deaths. The overall hazard ratio (HR) estimate of mortality in clinically anxious participants relative to controls was 1.09 (95 % CI 1.01-1.16); however, this was reduced after adjusting for publication bias (1.03; 95 % CI 0.95-1.13). There was no evidence of increased mortality risk among anxious participants derived from community samples (0.99; 95 % CI 0.96-1.02) and in studies that adjusted for a diagnosis of depression (1.01; 95 % CI 0.96-1.06). Conclusions These findings suggest that positive associations in the literature are attributable to studies in smaller samples, comorbid depression (or other psychiatric conditions) among participants, and possible confounding in medical patient samples followed-up for short durations.
Anxiety disorders are among the most prevalent and disabling mental health conditions across the globe [1-5], but the relationship between anxiety disorders and mortality is uncertain. Some studies have reported increased mortality risk [6, 7] , whereas others have reported no increase in risk [8, 9] , and some forms of anxiety have been associated with lower risk of death [8, 10] .
A recent meta-analysis that assessed the relationship between mental disorders and all-cause mortality observed that anxiety disorders are associated with an increased risk of death [11] . However, this study was criticized for a number of methodological shortcomings; for example, drawing inferences to the general population on the basis of a large number of studies conducted in patient samples [12] . Another recent meta-analysis that addressed the relationship between psychological distress and all-cause Electronic supplementary material The online version of this article (doi:10.1007/s00127-016-1284-6) contains supplementary material, which is available to authorized users. mortality also observed an increased risk of death among those with the symptoms of anxiety and depression [13] . However, this study was unable to disentangle the relative effects of anxiety and depression. Depression has been repeatedly found to be associated with an increased risk of death [11, [14] [15] [16] , and at least two independent studies have reported that mortality among individuals with comorbid depression and anxiety is attributable to depression [9, 17] . A more detailed understanding of the association between clinically significant anxiety and mortality is critical for evidence-based service provision and clinical decision-making.
The purpose of this study was to estimate the association between anxiety disorders, or clinically significant anxiety symptoms, and all-cause mortality by combining the results obtained from prospective cohort studies. The term 'clinically significant' is used to denote that anxiety symptoms were sufficient to meet the validated diagnostic threshold of the instrument. Three significant sources of uncertainty surrounding the relationship between anxiety and all-cause mortality include the population from which samples have been drawn; whether diagnoses were obtained from standardized clinical interviews or questionnaires; and whether depression was adjusted for. In this analysis, we address how the risk of all-cause mortality associated with clinically significant anxiety varies across these study characteristics.
Method Search strategy
We conducted this study according to the MOOSE guidelines for Meta-analyses and Systematic Reviews of Observational Studies [18] , and prospectively registered it with PROSPERO (CRD42015024706). We developed a search strategy for PubMed combining MeSH and open terms for anxiety, mortality, and prospective study design, which was later translated for other databases (EMBASE, PsycInfo, and CINAHL). Data Supplement 1 presents the search strategy for all of the databases. Searches were conducted in English through July 2015. We also handsearched the references of previously published systematic reviews for additional articles [11, [19] [20] [21] . A forward snowball search of all included studies was conducted in January 2016 using Google Scholar, to identify studies that may have been published up to 6 months after our initial search, and a backward snowball search was conducted to identify studies that the original search may have missed.
Study selection
We included the observational studies that assessed anxiety at baseline and all-cause mortality at follow-up using a prospective design, focusing on studies that measured anxiety disorders or symptoms using standardized structured clinical interviews based on DSM or ICD criteria or self-report questionnaires validated against these interviews. We excluded studies that did not use standardized instruments with valid definitions to diagnose anxiety and studies that did not include an asymptomatic control group. We also excluded studies with a follow-up period of 1 year or less to attenuate confounding from other potential proximal causes of mortality, such as a terminal physical illness, which would be associated with anxiety. Although all of the studies included in the present review reported hazard ratio (HR) estimates, we did not place an initial restriction against studies that did not report time-based measures of association based on the survival analyses. Following removal of duplicate records and an initial screen of all titles by one reviewer to discard irrelevant publications (BM), two independent reviewers examined each study abstract against the inclusion criteria (BM or AB or DGB). All disagreements were resolved through discussion.
Data extraction and quality assessment
Two reviewers (BM or DGB or AB) independently extracted information about the country, in which the study was conducted, sample size and characteristics, diagnostic instrument and anxiety sub-type or cut-off scores used, prevalence of anxiety, mortality ascertainment, total follow-up period, and adjustment for other variables using a data extraction form developed for this systematic review. Hazard ratios (HR) and 95 % confidence intervals were extracted for each study. We contacted authors of included records by email up to three times to obtain further information (e.g., clarification of definition of anxiety, missing, or unreported data). Multiple estimates were included from a single study if they were not overlapping (e.g., from different data sets or analyses were conducted in males and females separately). If multiple estimates were based on different sub-types or clinical interviews, only the most inclusive estimate was retained due to concerns about collinearity. Otherwise, if there were multiple estimates according to the same clinical definition, we opted for the most adjusted estimate, the estimate derived using the longest follow-up period, or using the cut-off score with the best overall psychometric properties against diagnostic interviews. We assessed methodological quality through a set of questions covering clear description of inclusion criteria, number of dropouts (non-mortality), adjustment for potential confounders, group allocation, and appropriateness of statistical analyses. Quality assessment was conducted using a modified version of the Newcastle-Ottawa Quality Assessment Scale [22] (See Data Supplement 2).
Meta-analyses
HRs were categorized according to the study sample (institutionalized/patient samples or not) and type of diagnostic instrument (interview vs. questionnaire). Randomeffects meta-analysis models were used to estimate pooled HR estimates [23] . The I 2 statistic was used to estimate the percentage of the total variation in effect sizes across studies attributable to heterogeneity [24] . Sub-group analyses were conducted according to sample type (community, patient, and veterans), diagnostic instrument (interview vs. questionnaire), and adjustment for depression.
Egger's test was used to indicate whether there was a bias of effect estimates (natural log of HR) relative to the precision of those estimates (standard error of the log of HR) [25] . Duval and Tweedie's [26] trim-and-fill method was used to account for publication bias by first removing biased estimates from the sample, and then refilling those estimates along with their ''missing'' counterparts imputed so as to maintain symmetry in the funnel plot. Finally, a sensitivity analysis was performed using random-effects meta-regression to examine the association of follow-up period with effect size (natural log of HR) in patient samples.
Results
The literature search of four databases and systematic reviews yielded 10,359 articles. After the removal of duplicate records, 7901 abstracts were screened and 328 articles met eligibility criteria. These full-text articles were screened and 45 eligible studies were subsequently extracted and quality assessed. Of those, seven articles were excluded from the meta-analysis, because of overlapping data with other articles, and two studies were excluded due to missing estimates. Forty-two estimates from 36 articles were included in the final meta-analysis [6-9, 27-58]. See Data Supplement 3 for flow chart of included studies.
Twenty-three estimates were based on medical patient samples, 15 were based on community samples, and four on veteran samples. Thirty estimates were obtained using self-report questionnaires, and 12 from structured diagnostic interviews. Thirty-four HRs were adjusted for covariates, and eight were not. Of those adjusted for covariates, 11 adjusted for comorbid depression. Eighteen studies had follow-up periods of 5 years or less, 14 studies had follow-up periods between 6 and 10 years, and 10 studies had follow-up periods of over 10 years. Twentyfive out of 36 studies were based in Europe, 6 in the USA, 4 in Australia, and 1 in China (See Data Supplement 4 for list of specific European countries by publication). The metaanalysis was based on 127,552 participants and over 11,573 deaths.
The overall pooled estimate of HR for all-cause mortality among people with anxiety disorders or clinically significant anxiety was 1.09 (95 % CI 1.01-1.16). The summary HRs were 1.79 (95 % CI 1.41-2.16) among veteran samples, 1.14 (95 % CI 0.98-1.30) among patient samples, and 0.99 (95 % CI 0.96-1.02) among community samples (See Fig. 1 ). Stratifying the analyses by adjustment for depression indicated that anxiety was positively associated with all-cause mortality when depression was unadjusted for (HR 1.18; 95 % CI 1.05-1.31); however, there was no evidence of an association between anxiety and all-cause mortality in studies adjusting for depression (HR 1.01; 95 % CI 0.96-1.06).
There was a moderate degree of heterogeneity between studies (I 2 = 52 %). Significant heterogeneity was observed between studies that did not adjust for depression (I 2 = 62 %), those that defined anxiety using self-report questionnaires (I 2 = 60 %), adjusted for covariates (I 2 = 58 %), and were based on patient samples (I 2 = 50 %). No heterogeneity was observed in studies adjusting for depression, or in studies conducted in community samples.
A funnel plot and results of Egger's test (p \ 0.01) suggested a publication bias favoring small studies with large, positive associations (see Data Supplement 5). Using a trim-and-fill method [26] , eleven estimates were imputed to adjust for missing studies. As a result, the overall HR was reduced to 1.03 (95 % CI 0.95-1.13).
Sensitivity analyses
A series of sensitivity analyses was conducted to better understand the factors contributing to heterogeneity in this study, and their impact on the overall HR estimate. Studies based on regression models that adjusted for covariates were found to account for a significant heterogeneity in this study; however, no heterogeneity was observed in studies that adjusted for depression and in estimates obtained from unadjusted models. Therefore, we compared estimates from models that adjusted for depression (among other variables) to models that were generally adjusted for covariates (excluding depression). Estimates based on unadjusted models (HR 1.04; 95 % CI 0.89-1.19) and on models adjusted for depression (HR 1.01; 95 % CI 0.96-1.06) were not associated with mortality, and displayed no heterogeneity. However, models that adjusted for covariates that excluded depression were positively associated with mortality (HR 1.23; 95 % CI 1.07-1.40), and exhibited the most substantial heterogeneity that was observed in this study (I 2 = 69 %). When we replaced 17 of the most adjusted estimates with their unadjusted or less adjusted counterparts, we found that the overall HR did not change. The removal of two outliers did not have a significant impact on these results either. Second, although we did not initially intend to exclude any study based on the type of estimate that was used (e.g., HR, OR, or RR), all but four estimates used survival analysis methodology to estimate HRs adjusted for time-to-event and censorship [59] [60] [61] [62] . We decided to exclude these four estimates (three ORs and one RR) from the primary analysis due to concerns about their comparability with the HR estimates. Repeating the analyses with the inclusion of these estimates increased the effect size by 0.01 after adjustment for publication bias and did not significantly influence these results. Third, all four estimates obtained from veteran samples, and a fifth estimate based on a medical sample, were based on a diagnosis of PTSD, which is no longer classified as an anxiety disorder in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorder (DSM-5). Repeating the analysis with the exclusion of these estimates increased the overall HR by 0.01 after adjustment for publication bias and did not significantly influence the overall pattern of results.
Finally, a random-effects meta-regression analysis was conducted to examine the relationship between follow-up periods and effect sizes. We expected that shorter followup periods would be associated with larger effect sizes specifically in medical patient samples, due to the influence of other proximal variables on mortality. A second-degree fractional polynomial (P 1 = -0.5, P 2 = -0.5) provided the best fit, indicating a decline in effect sizes up to approximately 5 years in patient samples (See Fig. 2) . The results of piecewise random-effects meta-regression analyses split at 5 years of follow-up indicated a significant decrease in effect size with increasing follow-up period up to 5 years (b = -0.23; 95 % CI -0.37, -0.09; p = 0.004), and no association between follow-up period and effect size 5 years and after (b = 0.01; 95 % CI -0.02, 0.04; p = 0.5). No statistically significant relationship between follow-up period and effect size was observed in community samples.
Discussion
We conducted a systematic review and meta-analysis of prospective cohort studies that reported HRs of the association between anxiety disorders, or clinically significant anxiety symptoms, and all-cause mortality. The overall HR indicated that anxiety was positively associated with mortality; however, this was not the case after adjusting for publication bias. Sub-group analyses revealed no evidence of increased mortality risk in community samples, or in studies that adjusted for depression. The largest heterogeneity that was observed was among studies that did not adjust for depression, and among studies based on adjusted models (particularly, those that adjusted for covariates excluding depression).
Anxiety is among the most prevalent mental disorders in the world [1, 3], and has been estimated to account for approximately 15 % of disability-adjusted life years (DALYs) attributable to mental disorders [4] . The finding that anxiety is not associated with mortality after adjustment for depression suggests that the mortality risk attributable to anxiety in the unadjusted studies may be due to comorbid depression. Indeed, anxiety and depression have been found to co-occur substantially, as measured during the past-year or over the lifetime [63] [64] [65] , and a number of studies have found that depression is independently associated with an increased risk of death [11, [14] [15] [16] 20] . Several studies have also found that depression accounts for higher proportions of the global burden of disease than anxiety, as measured by DALYs and annual expenditures [4, 66] . However, it is also possible that depression among individuals with anxiety is a better indicator of other comorbidities, such as substance disorders, that are also substantially associated with disease and mortality [4, 8] .
There was no evidence of an association between anxiety and mortality in community samples; however, a positive association was observed in veteran samples and a positive trend was observed in patient samples. One explanation of these findings is that anxiety might exacerbate outcomes particularly among individuals of poorer health, or that anxiety may be associated with increased risk of some medical conditions that mediate the link with mortality. For example, anxiety may be associated with increased risk of incident cardiovascular and metabolic diseases [67, 68] . A similar explanation could also be invoked for the findings in veterans: one of the four veteran In addition, all of the veteran samples were assessed only for PTSD, which, although no longer categorized as an anxiety disorder in the DSM-5, may have a stronger association with mortality than the other exposures in this study. A second possibility is that the increased mortality risk observed in veteran and patient samples is not due to anxiety. Individuals with poorer health status are at higher risk of mortality irrespective of anxiety, and anxiety may reflect poorer health. For example, the prevalence of anxiety is pronounced in medical samples [70] [71] [72] [73] [74] [75] [76] , and those with recently diagnosed illnesses tend to report higher anxiety symptoms [77] [78] [79] . Finally, these findings may also be attributable to depression: whereas 8 out of 15 studies in community samples adjusted for depression, only 3 out of 23 of the studies conducted in patient samples and none of the veteran samples adjusted for depression. Indeed, a recent meta-analysis of studies conducted in transplant patients found that whereas depression was associated with increased mortality risk, anxiety was not [20] .
There was also evidence of a publication bias of studies addressing the relationship of anxiety and all-cause mortality, such that smaller studies more frequently reported larger HR estimates. After adjusting for this publication bias, there was no evidence of a significant effect of anxiety on mortality. Exploratory analyses indicated that studies conducted in patient samples with up to 5 years of follow-up tended to have inflated effect estimates, possibly due to confounding from other proximal influences on mortality.
The comprehensive search strategy employed in this study is a significant strength: only prospective cohort studies that reported using validated diagnostic instruments to measure anxiety, and included asymptomatic controls, with greater than 1-year follow-up and that adjusted for time-to-event were included. However, the stringency of our criteria sometimes led to the exclusion of otherwise high-quality studies, and as a result, we were unable to examine how estimates vary as a result of other study characteristics and outcomes. For example, some otherwise strong studies did not report using the standardized instruments or valid definitions to diagnose clinically significant anxiety symptoms [80, 81] , ascertained anxiety retrospectively [82], or assessed mortality by specific causes [83] . In addition, some studies in patient samples that used valid measures of anxiety and used prospective designs were excluded, because they combined clinically adverse events with mortality as the main outcome [84, 85] . It is possible that anxiety disorders are associated with increased risk of mortality due to some specific causes; for example, suicide attempts [86, 87] . Anxiety does not appear to be associated with increased mortality among patients with coronary heart disease [19] , despite the results of one meta-analysis suggesting that anxiety is associated with higher incidence of coronary heart disease [67]. However, depression has been found to be associated with increased risk of mortality among patients with coronary heart disease [88] .
More work is needed to investigate the relative contributions of depression and anxiety to disease outcomes and all-cause and cause-specific mortality. Specifically, due to the frequent co-occurrence of these disorders, it is important for future work to adjust for one disorder when addressing the relationship of the other with the incident physical conditions, adverse medical outcomes, or mortality risk. It is also important for future studies to assess the role of substance use [89] [90] [91] [92] [93] , physical activity [94, 95] , inflammatory markers, diet, and other potential intermediary variables. The previous studies have reported that such behavioral and biologic variables mediate the relationship between depression and all-cause mortality [96, 97] , however, whether these also explain that the relationship between anxiety and all-cause mortality has to our knowledge remained unexplored.
It is possible that the relationship of anxiety and mortality depends on the nature of the anxiety. Obsessive-compulsive disorder, although no longer classified as an anxiety disorder by the DSM-5, captures anxiety-related characteristics that may be associated with lower risk of death, because the individual is more likely to take protective actions [8, 98, 99] . Other anxiety disorders may be associated with higher risk of mortality, such as panic disorder, associated with strong physiological activity; blood illness phobia, associated with avoidance of preventive medical treatment; or agoraphobia, associated with both possibilities. The resulting mixture of all types of anxiety disorders, of necessity the focus of this review, may have contributed to the null result found in this study.
Relative to asymptomatic controls, there was no evidence of an increased risk of mortality among individuals with anxiety disorders or clinically significant anxiety symptoms. These findings were obtained with the highest consistency in community samples and when depression was adjusted for, suggesting that the positive association between anxiety and mortality in some studies may be attributable to comorbid depression, or to other medical comorbidities among studies conducted in veteran and patient samples. 
